Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

In The News

Moderna is developing three new mRNA-based vaccines for seasonal flu, HIV and Nipah virus

Tech Crunch

January 11, 2021

Read more

In The News

Moderna using mRNA technology to create vaccines for seasonal flu, HIV and Nipah virus, company says

Fox News

January 11, 2021

Read more

Scientific Publications

Response to Inclusion as Illusion Erasing Transgender Women in Research with MSM

Read more

Features

Donor Spotlight: European & Developing Countries Clinical Trials Partnership

December 7, 2020

IAVI recognizes the European & Developing Countries Clinical Trials Partnership (EDCTP) for its continued commitment to supporting Europe and sub-Saharan Africa research collaborations and capacity building that work to accelerate the development and uptake of new and improved clinical interventions to combat HIV/AIDS, tuberculosis, and other infectious and neglected diseases.

Read more

Press Releases

IAVI Announces Launch of EDCTP-funded Socio-behavioral Project on Accessible HIV Prevention Tools for African Women

December 3, 2020

Universally accessible HIV Prevention Technologies for African girls and young women through Knowledge applied from behavioral Economics (UPTAKE) presents a unique multidisciplinary collaboration of five leading research institutions in both Africa and Europe.

Read more

Features

HIV Activist Winifred Ikilai: 5 Things to Know on World AIDS Day 2020

December 1, 2020

This World AIDS Day, 2020 AVAC Advocacy Fellow Winifred Ikilai shares her a community perspective on the need to ensure globally accessible tools to end the HIV epidemic.

Read more

In The News

Comet tails and a Trojan horse: One laboratory’s hunt for a COVID-19 vaccine

Los Angeles Times

November 13, 2020

Read more

Features

Study finds long-acting injectable HIV prevention option is effective for cisgender women

November 9, 2020

IAVI welcomes evidence of long-acting cabotegravir’s safety and efficacy in cisgender women.

Read more